Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M M Mansaray
Observed name:
Mohamed Mansaray
Institutions:
London School of Hygiene & Tropical Medicine,
Mwanza Intervention Trials Unit,
National Institute for Medical Research
Observed institutions:
London School of Hygiene & Tropical Medicine,
Mwanza Intervention Trials Unit,
National Institute for Medical Research
OpenAlex ID:
A5024887281
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2021
·
David Ishola
, Daniela Manno
, et al.
·
The Lancet Infectious Diseases
·
105
PDF
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2021
·
Muhammed O Afolabi
, David Ishola
, et al.
·
The Lancet Infectious Diseases
·
102
PDF
Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone
2018
·
Jessica G. Shantha
, John G. Mattia
, et al.
·
EBioMedicine
·
61
PDF
Assessment of Ebola virus persistence in vitreous fluid of Ebola virus disease survivors with vitreoretinal disease in Sierra Leone: a cross-sectional study
2026
·
Susanne L Linderman
, Tolulope Fashina
, et al.
·
The Lancet Microbe
Show more works
View as search
Works count:
3
Citation count:
267
H-index:
3
I10-index:
3
Year
Topic
Type